Bionano Genomics, Inc. Restructuring Costs
Bionano Genomics, Inc. (BNGO) reported Restructuring Costs of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-23.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2026-03-23
- Bionano Genomics, Inc. restructuring costs for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Bionano Genomics, Inc. restructuring costs for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Bionano Genomics, Inc. restructuring costs for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Bionano Genomics, Inc. restructuring costs for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Bionano Genomics, Inc. restructuring costs for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Bionano Genomics, Inc. restructuring costs for fiscal 2024 was $8.02M, a 982.59% increase from fiscal 2023.
- Bionano Genomics, Inc. restructuring costs for fiscal 2023 was $741.00K.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $0.00 derived: sum of 2 quarters · filed 2026-03-23 | $0.00 derived: sum of 3 quarters · filed 2026-03-23 | $0.00 10-K · filed 2026-03-23 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | $406.00K derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $406.00K derived: sum of 3 quarters · filed 2026-03-23 | $2.18M derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | $406.00K derived: sum of 2 quarters · filed 2026-03-23 | $2.18M derived: sum of 3 quarters · filed 2026-03-23 | $3.39M derived: sum of 4 quarters · filed 2026-03-23 |
| 2024-12-31 | $406.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $2.18M derived: sum of 2 quarters · filed 2026-03-23 | $3.39M derived: sum of 3 quarters · filed 2026-03-23 | $8.02M 10-K · filed 2026-03-23 |
| 2024-09-30 | $1.77M 10-Q · filed 2025-11-13 | $2.98M derived: sum of 2 quarters · filed 2025-11-13 | $7.62M 10-Q · filed 2025-11-13 | $8.36M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $1.22M 10-Q · filed 2025-08-14 | $5.85M 10-Q · filed 2025-08-14 | $6.59M derived: sum of 3 quarters · filed 2025-08-14 | $6.59M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $4.63M 10-Q · filed 2025-05-14 | $5.37M derived: sum of 2 quarters · filed 2025-05-14 | $5.37M derived: sum of 3 quarters · filed 2025-05-14 | $5.37M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $741.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $741.00K derived: sum of 2 quarters · filed 2025-03-31 | $741.00K derived: sum of 3 quarters · filed 2025-03-31 | $741.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |